1/205
Looks like no tags are added yet.
Why Parkinson's Disease and Alzheimer's Disease
Incidence of both increases with age
Population is aging (2030, proportion of the population >65, 20%)
Huge impact on health care (NIA projecting 14 million with AD by 2040)
Alzheimer's disesae
Most common cause of dementia (65%)
Begins after 60, risk goes up with age
PROGRESSIVE loss of cognitive function
---memory
---judgement and reasoning
---movement coordination
Central Nervous System Involvement
Alzheimers disease begins in the hippocampus, spreads to cerebral cortex
--Neuritic plaque
--Neurofibrillary tangles
--Cell loss
---Loss of Acetylcholine
Develops slowly over time
Neuritic plaques
abnormal clumps of protein (amyloid) outside the neuron
Neurofibrillary tangles
twisted proteins (tau) inside the neuron
Mild Alzheimers signs and symptoms
mild forgetfullness
Moderate Alzheimers signs and symptoms
Severe memory loss
Can't do simple tasks
Speaking, writing
Personality change
Severe Alzheimers signs and symptoms
Unable to take care of themselves
Wandering
Gait/balance disturbances (falls)
Causes/Risk Factors of Alzheimer's Disease
Age (older)
Female
Genetic Link
HBP, High cholesterol
Sedentary lifestyle
Education
Genetic link with AD
ApOE4 (double allele)
Risk increases 4-fold if first degree relative has AD; risk increases 40 fold if 2 or more first degree relatives have AD
Sedentary lifestyle AD
Survey of people with AD and healthy family control of midlife activities
--Persons with AD, greater time spent watching TV
--Each additional hour of TV watching increased risk of AD by a factor of 1.3
Education with AD
109 pairs of twins one had AD and other had no AD
Treatment of AD
No cure
Medications - Aricept, Exelon
Keep as physically and mentally active as possible
New findings in mice: hope for a cure
Prevention (delay) Stay active!
Exercise (large prospective studies)
--increased exercise showed a decrease in cognitive decline
--Engaged 4 or more physical activities, half risk of dementia compared to those in one or none (not absolute energy expenditure, but number of activities)
--What's good for the heart is good for the mind
How does exercise impact cognition?
Increased blood flow
Brain derived neurotrophic factor
Work in conjunction with estrogen
Parkinson's Disease
-Disease of the ganglia
-Primarily older adults
-More common in men than women
-Most common among Hispanics followed by non-Hispanic Whites, Asians, and Blacks
-Affects movement primarily, but can eventually affect cognition and emotion
Basal ganglia
substantia nigra
Substantia nigra
produces dopamine (neurotransmitter)
Parkinson's disease where and why
With age: death of cells 70-80% Parkinson's Disease symptoms
Cause of additional cell death? Unknown
PD Cause idiopathic
Genetics: positive family history
Environmental: herbicides, pesticides, heavy metals, proximity to industry, rural residence, well water, welders have higher incidence
Head trauma
Drugs
Cardinal Characteristics of PD
-Resting tremor
-Bradykinesia: slow movement
-Akinesia: slowness to initiate movement
-Rigidity (cogwheel movement)
-Movement sequencing
-Postural instability
-Fatigue
Bradykinesia
slow movement
Akinesia
slowness to initiate movement
Additional signs and symptoms of PD
-Masked face
-Stooped, shuffling gait (festination)
-Decreased arm swing when walking
-Difficulty initiating movement
-Microphagia
-Soft speech
-Slow to initiate speech
-Loss of the sense of smell
Non-motor symptoms of PD
Sleep disorders
Cognitive impairment
Depression
- 40-90% patients
-Endogenous depression (chemical changes, not stressful life event)
-Reduction in QOL
-Depression and panic attacks precede motor symptoms in 30%
PD Basal Ganglia
less activation which, in turn, results in less activation of the planning areas of the motor cortex
Basic principles of medical treatment for PD
Current therapies/drugs treat symptoms
Treat according to functional deficit
-varies with the individual
Long term planning
-now live only 1-1.5 years less than if no disease
-chronic illness
-QOL issues
PD Treatment
Drugs: Levodopa and carbidopa (Sinemet)
Surgery
-lesion areas or insert simulators
Deep Brain Stimulation
Therapeutic intervention for PD
Encouraged to stay active
Flexibility, strength
Research in MC/L Lab: coordination
-learning complex movements more slowly
-need more augmented feedback
-once learned, retained (possible exception, memory driven skills)
-memory driven movements more difficult
BIG and LOUD speech therapy
Hunington's Disease
Disease of basal ganglia
Genetic (cell death) - chromosome 4
Age: 30-40s that already have children
Both motor and cognitive symptoms
Too much movement - writing, tics
Ultimately fatal
Those on PD meds too long have HD motor symptoms
Multiple sclerosis
Primarily young adults
-onset in 20 to 40 years olds
More common in
-women
-caucasians (northern European ancestry)
-areas farther away from equator
Multiple sclerosis CNS involvement
Progressive demyelination of axons
-Myelin around axons degenerates (white matter)
-Axon degeneration
Can occur in CNS or PNS
-Any area in the brain
-Motor or sensory neurons
Short circuits and slow signals
Etiology of multiple sclerosis
Believed to be an auto immune disease
-Immune system attacks itself
Causes inflammation, which breaks down myelin
Scarring (sclerosis) forms plaques
Causes of multiple scleorsis
Unknown
Genetics contribute
Vitamin D deficiency
Viruses that infect nervous system
May be stress related
Early symptoms of multiple sclerosis
Wide variation
-(affects different parts of CNS and/or PNS)
Sensory numbness or tingling
Muscular weakness or incoordination
Visual difficulties (one eye affected)
Vertigo
Fatigue
Decreased memory, poor reasoning
Depression
Progression of multiple sclerosis
Remission, re-occur
Gait affected (use of wheel chair)
Rigidity, spasticity
Poor speech
Any early symptoms with greater severity
Multiple sclerosis treatment
Corticosteroids (to reduce inflammation)
Exercise (try to stay active as possible, yoga, tai chi)
Avoid stress and fatigue (avoid increasing core temperature)
Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig Disease)
Cause: genetic
Attacks cell bodies in motor areas of cerebral cortex and corticospinal tract axons
Motor symptoms, disabling, usually dying from respiratory failure
Degenerative diseases cerebral cortex
Alzheimer's disease
Degenerative diseases basal ganglia
Parkinson's disease
Huntington's disease
Degenerative diseases white matter
Multiple sclerosis
Degenerative diseases gray matter
Amyotrophic Lateral Sclerosis
Cerebral Palsy
Disorder of posture and movement that is non-progressive/non-hereditary
Prevalence: 1-2 per 1000 children
More in low birth weight infants (50% of cases)
More in caucasians and in males
More prevalent in premature births
Etiology of Cerebral Palsy
Damage to CNS prior to, during or soon after birth
Insult while brain is rapidly developing
Note: hypoxia is not a primary contributor (human error)
Severity dependent upon degree damage
Characteristics of Cerebral Palsy
Spastic (motor cortex)
-sudden muscle contractions
-tense/contracted muscles
Athetoid (basal ganglia)
-writhing, uncontrolled movements of the limbs, head, and eyes
Ataxic (cerebellum)
-poor coordination, timing
-poor balance
Can involve upper or lower limbs, trunk, neck, speech
Scoliosis
Associated involvement: cognition, language and vision
Treatment of Cerebral Palsy
Medication for rigidity (baclofen pump)
Rehabilitation therapy
-increase strength and range of motion
-improve coordination
Rhizotomy
-severing some sensory neurons to reduce spasticity in legs
Orthopedic
-tendon lengthening
-rods in backs
Assistive technologies
-wheelchair, communication
Stroke: Cerebrovascular Accident (CVA)
Any sudden spontaneous vascular event in the brain
Not a neurological disease
Disease that affects blood flow, which in turn damages the brain
Stroke statistics
-750,000 people/yr, 66% survival rate
-Third leading cause of death in the US
-The leading cause of diability
-Most frequent reasons for admission to nursing home
-Costs $30 billion annually
-More common in elderly >60 year old
-20% occur in persons
Non-modifiable risk factors for stroke
Age >60 (20%
Modifiable risk factors for stroke
-HBP: single most important modifiable risk factor
-coronary artery disease
-high cholesterol
-diabetes
-smoking
-alcohol abuse
-obesity
-lack of physical activity
-use of oral contraception
-sleep apnea
Subarachnoid space
is the space which normally exists between the arachnoid and the pia mater, which is filled with cerebrospinal fluid
Types of stroke
Epidural hematoma
Subdural hematoma
Subarachnoid hemorrhage
Hemorrhagic stroke
Ischemic stroke
Epidural hematoma
Beneath skull, but outside dura mater
Skull fracture arterial, so fast blood loss; lucid interval
Subdural hematoma
Beneath dura mater
Abrupt motion of head leads to venous, so slow blood loss
Subarachnoid hemorrhage
Subarachnoid space
Spontaneous is arterial, so fast
Hemorrhagic stroke
"Red stroke" bleeding in the brain
Chronic hypertension causing aneurysms; fatal
Ischemic stroke
"White stroke" lack of oxygen to brain typically due to blood clot - kills brain cells
85% OF ALL STROKES
Treatment: anticoagulant therapy (heparin)
Impairment post stroke depends on
Condition of person prior to stroke
Where in the brain, and size of damaged area
Type of stroke
Ischemic stroke sides
Left hemispheric damage: right side of body
Right hemisphere damage: left side of body
Common stroke impairments cognitive
Confusion
Personality changes
Apraxia
Neglect
Receptive aphasia
Common stroke impairments motor
Weakness
Spasticity
Balance of difficulties
Loss of sensation, or hypersensitivity
Expressive aphasia
Stroke treatment: role of exercise
Rehabilitative/Recovery of Function
Acute: basic functions
-Goals: go home, be safe, decrease fall risk
-Physical, occupational, and speech therapy
Chronic: conditioning/fitness
-Goals: increased fitness levels, reducing risk factor to prevent second stroke, help with depression
Stroke prevention: role of exercise
Prospective Studies examining LTPA and PA
-Followed 22,000 men, asked about their PA, relative risk for stroke decreased as PA increased, dose-response manner
-Followed 72,000 women since 1986, again found that increased PA DECREASED RISK FOR STROKE
Bone-related conditions
Osteoporosis
Osteoarthritis
Neuromuscular conditions
Fibromyalgia
Muscular Dystrophy
Musculoskeletal health
65+ Population is aging
-31 million in 2000
-40 million in 2010
-72 million projected in 2030
-88.5 million by 2050
1 in 5 over 65 years by 2030
Biology of bone mechanical
Structural support for heart, lungs and marrow
Protection for brain, uterus, and other internal organs
Attachment sites for muscles allowing limb movement
Biology of bone metabolic
Mineral reservoir for 99% of the body's calcium, 85% of phosphorous and 65% of the sodium
Biology of bone hematopoietic
Bone marrow makes red and white blood cells and platelets
Biology of bone architecture
Cancellous (trabecular or spongy)
Cortical (compact or solid)
CTM
Cortical bone
Trabecular bone
Marrow tissue
Cancellous (trabecular or spongy)
supporting strength to ends of weight-bearing bone
Cortical (compact or solid)
forms shaft of long bone, on the outside
Osteoblasts
bone formation and lining cells (cover surface of bone)
B in blast B for BUILD
Osteoclasts
resorb/dissolve bone
release calcium to blood
Osteocytes
Maintenance
Transport metabolites
Cell communication
Regulate mineral balance
Remodeling regulated by
Parathyroid hormone (stimulates osteoclasts)
Thyroid hormone (stimulates osteoblasts)
Sex hormones (estrogen: suppresses activity of osteoclasts)
Vitamin D
Wolf's Law
Bone is laid down where it is needed (in response to stress) and resorbed where it is not needed
Minimal essential strain
-Threshold signal is sent to osteoblasts; if threshold signal is not met, osteoclasts are produced to resorb bone
Factors that determine peak bone mass
Genetic factors
Hormonal milieu
Mechanical loading
Nutritional factors
Other factors
Late 20/early 30s
typical peak bone mass
Etiology of osteoporosis
Characterized by decreased bone mass and structural deterioration of bone tissue, leading to bone fragility and increased susceptibility to fractures
Metabolic bone disorder resulting from resorption of calcium from bone
Osteo means
bone
Porous means
full of holes
Diagnosis of osteoporosis
1. Bone mineral density (BMD)
2. Laboratory biochemical markers
3. Bone biopsy with pathologic
Bone mineral density (BMD)
is the weight of mineral per unit volume of bone (how many minerals are deposited in the bone or how porous the bone is)
-DEXA (Dual energy x-ray absorptiometry)
-Quantitative CT Scan
-Quantitative Ultrasound
Laboratory biochemical markers
Circulating calcium, vitamin D, and estrogen levels
WHO definitions of osteoporosis
T-Score -1.0 and above = normal BMD
T-Score -1.0-2.5 = low bone mass (osteopenia)
T-Score -2.5 and below = osteoporosis
T-Score -2.5 and fragility fracture present = severe osteoporosis
Prevalence of osteoporsis
-44 million Americans potentially affected
-10 million individuals have osteoporosis; 34 million have low bone mass = increased risk
-Gender
--80% affected are women
--Loss of bone mass with aging, perhaps 0.7% per year in adults
--Women may lose 20% bone density in 5-7 years after menopause
-Fracture risk
--1 in 2 women and 1 in 4 men over 50 will have an osteoporosis related fracture in their lifetime
-Caucasian women have 2x fracture incidence as African-American women
-Race/Ethnicity
--20% caucasian and Asian women, 7% men
--10% Hispanic women 3% men
--5% African American women, 4% men
--Risk is increasing most rapidly in hispanic women
Osteoporosis risk factors
Gender
Age >70 years
Caucasian or Asian race
Small frame/low weight
Heritability (40-70% BMD)
Nutritional issues
Sedentary lifestyle
Low vitamin D levels
Smoking!
Medications
Inadequate estrogen/testosterone
Importance of vitamin D
Lowest fracture risk when vitamin D serum between 24-32 mg/dl
May be associated with mortality, morbidity, cancer, multiple sclerosis, diabetes, osteoarthritis, fibromyalgia
Consequences of osteoporosis
Compression fracture
Kyphosis
-shortening of the spine
Falls
-femur (hip) 24% over age 50 die in 1st year
-6 months post-fracture, only 15% walk across room without aid
-spine
-wrist
Preventing osteoporosis
Athletic youngsters or individuals active in sport during youth possess greater BMD than non-athletic persons ("bank account" during youth) site specific formation of bone: sport related
Physical activity: walking 4 hrs/week = 40% reduction in hip fractures
Nutrition (supplements)
-Total calcium: 1,200 mg/day
-Vitamin D: 800-1000 IU/day supplement
Fall prevention for older adults
1. keep bathroom lights on
2. install grab bars
3. avoid loose rugs
4. remove clutter
5. keep wires behind furniture
Treatment of osteoporosis
Dietary calcium
Vitamin D supplements
Physical activity
Hormone replacement therapy (estrogen)
Pharmacologic Intervention
-Biphosphonates (reclast, fosamax, Actonel) stimulates apoptosis of osteoclasts
-Estrogen receptor agonists (Evista/Tamoxifen) protects osteoblasts from apoptosis
-Parathyroid hormone (Forteo) stimulates osteoblast activity
Exercising with osteoporosis
Weight bearing aerobic activities (3-5 days/wk) and resistance exercises (2-3 d/wk)
-stair climbing, walking, weight lifting
-moderate intensity: 40-60% VO2R or HRR $ 8-12 repetitions
Balance training
Avoid explosive movements or high impact loading
Avoid exercise causing twisting, bending, or compression of the spine (sit ups, hypertension)
Osteoarthritis
There are more than 100 different types of arthritis
Osteoarthritis is the most common
Etiology of osteoarthritis
Primary: typically due to heredity and mechanical factors with overuse; aging
-unknown etiology
-affects spine, hip, or knee (weight bearing joints)
Secondary: history of injury or trauma
-associated obesity
-congential abnormality
-diabetes, gout, etc
-often lower extremity affected
Background osteoarthritis
Chronic, progressive disorder causing deterioration of joint cartilage and bone
Cartilage
-becomes rigid and thin
-easily damaged by use or injury
Bone
-thickening bone
-bone spurs
Fragment of bone or cartilage may float in joint space
Joint lining becomes inflamed ("joint inflammation)
Not systematic - localized
Osteoarthritis symptoms
Pain
Crepitus (grinding)
Swelling leads to cartilage deterioration
Lose motion leading to joint deformity
Diagnosis of osteoarthritis
Diagnosis based on
-Physical exam
-Symptom history
-X-rays (advanced disease)
--loss of cartilage
--joint space narrowing
--spur formation
-No current blood test for OA